Replay available

Medpace Holdings, Inc. (MEDP) Q4 2025 Earnings Call

Medpace Holdings, Inc. (NASDAQ: MEDP) Q4 2025 earnings conference call, held 2026-02-10. Replay captured from the company's public earnings webcast.

Tue, February 10, 2026 at 9:00 AMendedReplay
Medpace Holdings, Inc. (MEDP) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Lauren Morse

Director of Investor Relations

August Trendle

Chief Executive Officer

Jesse Geiger

President

Kevin Brady

Chief Financial Officer

Christine Raines

Analyst, William Blair

Justin Bowers

Analyst, Deutsche Bank

Anne Hines

Analyst, Mizuho Securities

David Windley

Analyst, Jefferies

Charles Rahee

Analyst, TD Cowan

Sean Dodge

Analyst, BMO Capital Markets

Jalyn Dressing

Analyst, Truist Securities

Dan Leonard

Analyst, UBS

Dan Clark

Analyst, LeRank Partners

Jay Lewis

Analyst, Baird

Replay transcript excerpt

Good day ladies and gentlemen and welcome to the MedPace fourth quarter and full year 2025 earnings conference call. At this time all participants are in a lesson only mode. After the speaker's remarks there will be a question and answer session. If you'd like to ask a question please press star one on one on your telephone. If your question has been answered or you'd like to remove yourself from the queue simply press star one one again. As a reminder this call is being recorded. I would now like to introduce your host for today's conference call Lauren Morse, MedPace's Director of Investor Relations. You may begin. Good morning, and thank you for joining MedPace's fourth quarter and full year 2025 earnings conference call. Also on the call today is our CEO, August Trendle, our President, Jesse Geiger, and our CFO, Kevin Brady. Before we begin, I would like to remind you that our remarks and responses to your questions during this teleconference may include forward-looking statements within the meaning of the Private Security Litigation Reform Act of 1995. These statements involve inherent assumptions with known and unknown risks and uncertainties, as well as other important factors that could cause actual results to differ materially from our current expectations. These factors are discussed in our Form 10-K and other filings with the SEC. Please note that we assume no obligation to update forward-looking statements, even if estimates change. Accordingly, you should not rely on any of today's forward-looking statements as representing our views as of any date after today. During this call, we will also be referring to certain non-GAAP financial measures. These non-GAAP measures are not superior or a replacement for the comparable GAAP measures, but we believe these...

More from Medpace Holdings, Inc.